Patents by Inventor Che-Kun J. Shen

Che-Kun J. Shen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4196281
    Abstract: New psoralen compounds have been synthesized. The compounds all include the addition of substituent groups at the 4' position on the basic trioxsalen structure. Specifically, the compounds have the structure: ##STR1## wherein X may be any desired substituent such as halogenated alkyls, alcohols, ethers, aminoalkyls, etc. The new substituted psoralens exhibit high solubility in aqueous solution and low dissociation constants from deoxyribonucleic acid (DNA), as well as a reactivity with ribonucleic acids (RNA). The psoralen-DNA and psoralen-RNA adducts are useful as a substrate for studying the secondary structures of nucleic acids.
    Type: Grant
    Filed: August 31, 1978
    Date of Patent: April 1, 1980
    Assignee: Regents of the University of California
    Inventors: John E. Hearst, Henry Rapoport, Stephen Isaacs, Che-Kun J. Shen
  • Patent number: 4169204
    Abstract: New psoralen compounds have been synthesized. The compounds all include the addition of substituent groups at the 4'-position on the basic trioxsalen structure. Specifically, the compounds have the structure ##STR1## wherein ##STR2## where R is a mono or dicyclic radical which can contain one additional hetero atom in the nitrogen containing ring.The new substituted psoralens exhibit high solubility in aqueous solution and low dissociation constants from deoxyribonucleic acid (DNA), as well as a reactivity with ribonucleic acids (RNA).
    Type: Grant
    Filed: August 28, 1978
    Date of Patent: September 25, 1979
    Assignee: Regents of the University of California
    Inventors: John E. Hearst, Henry Rapoport, Stephen Isaacs, Che-Kun J. Shen
  • Patent number: 4124598
    Abstract: New psoralen compounds have been synthesized. The compounds all include the addition of substituent groups at the 4' position on the basic trioxsalen structure. Specifically, the compounds have the structure: ##STR1## wherein X may be any desired substituent such as halogenated alkyls, alcohols, ethers, aminoalkyls, etc. The new substituted psoralens exhibit high solubility in aqueous solution and low dissociation constants from deoxyribonucleic acid (DNA), as well as a reactivity with ribonucleic acids (RNA). Such psoralen compounds find use in the study of secondary structures of nucleic acids; as inhibitors of RNA replication; in the inactivation of viruses; and in the photo chemotherapy of psoriasis.
    Type: Grant
    Filed: October 20, 1976
    Date of Patent: November 7, 1978
    Assignee: Hoffmann-La Roche Inc.
    Inventors: John E. Hearst, Henry Rapoport, Stephen Isaacs, Che-Kun J. Shen